GlaxoSmithKline PLC Investor Update Transcript
Good morning and good afternoon. I'm Iain Mackay, CFO of GSK. And it's my pleasure to welcome you to our investor update.
We have a packed agenda, which I'll detail in just a minute.
However, before I do that, I'd like to mention a couple of housekeeping details. First, you should have received our press release and you can view the presentation on GSK's website. For those not able to view the webcast, the slides that accompany today's event are located on the investor section of the GSK website. Second, during the question-and-answer session, we would ask that you limit your questions to 2 so that everyone has the chance to participate.
Before I begin, please refer to Slide 2 of our presentation for our cautionary statements, and our basis of preparation can be found in the appendix. And with that, we'll move to Slide 3, and let me take you briefly through our agenda.
Our speakers today are Emma Walmsley, Luke Miels, Dr. Hal Barron, Deborah Waterhouse, Dr. Kimberly Smith and myself, and Roger
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
